UBS Hosts Global Pharmaceuticals Conference.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System (NYSE NYSE See: New York Stock Exchange :UBS):
WHAT: The UBS Global Pharmaceuticals Conference will feature
presentations by over 90 pharmaceutical companies from 14
different countries. The preliminary list of presenting
companies includes:
Acambis plc
Advancis Pharmaceutical Corp.
Alimera Sciences
Alkermes, Inc.
Anadys Pharmaceuticals, Inc.
Andrx Corporation
Angiotech Pharmaceuticals, Inc.
Antares Pharma, Inc.
Auxilium Pharmaceuticals, Inc.
Axcan Pharma Inc.
Barr Pharmaceuticals, Inc.
Barrier Therapeutics, Inc.
Berna Biotech AG
betapharm Arzneimittel GmbH
Bioenvision, Inc.
BioSante Pharmaceuticals, Inc.
Biovail Corporation
Bradley Pharmaceuticals, Inc.
Cadila Healthcare Ltd.
CardioKine, Inc.
Cardiome Pharma Corp.
Celgene Corporation
Columbia Laboratories, Inc.
ConjuChem Inc.
Curis, Inc.
Cypress Bioscience, Inc.
CytRx Corporation
EGIS Pharmaceuticals Ltd.
Encysive Pharmaceuticals Inc.
Endo Pharmaceuticals Holdings Inc.
EPIX Pharmaceuticals, Inc.
Eyetech Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
First Horizon Pharmaceuticals Corp.
Flamel Technologies S.A.
Genaera Corporation
Geron Corporation
Glenmark Pharmaceuticals Limited
Hi-Tech Pharmacal Co., Inc.
Icagen, Inc.
Inamed Corporation
Inhibitex, Inc.
InKine Pharmaceutical Company, Inc.
Isolagen, Inc.
ISTA Pharmaceuticals, Inc.
IVAX Corporation
Jubilant Organosys, Ltd.
King Pharmaceuticals, Inc.
K-V Pharmaceutical Company
Labopharm Inc.
Ligand Pharmaceuticals Incorporated
Lupin Limited
Matrixx Initiatives, Inc.
The Medicines Company
Medicis Pharmaceutical Corporation
MGI Pharma, Inc.
Nabi Biopharmaceuticals
Nastech Pharmaceutical Company Inc.
Nektar Therapeutics
NeoPharm, Inc.
Neose Technologies, Inc.
Neurochem Inc.
New River Pharmaceuticals Inc.
Northfield Laboratories Inc.
Novavax, Inc.
Novozymes A/S
Pain Therapeutics, Inc.
Paladin Labs Inc.
Palatin Technologies, Inc.
Pharmion Corporation
PLIVA d.d
Pozen, Inc.
Progenics Pharmaceuticals, Inc.
Prometheus Laboratories Inc.
QLT Inc.
Ranbaxy Laboratories Limited
Recordati S.p.A.
Rigel Pharmaceuticals, Inc.
Salix Pharmaceuticals, Ltd.
Santarus, Inc.
Savient Pharmaceuticals, Inc.
ScinoPharm Taiwan, Ltd.
Sepracor Inc.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SkyePharma PLC
Somaxon Pharmaceuticals, Inc.
SuperGen, Inc.
Taro Pharmaceutical Industries Ltd.
Telik, Inc.
UCB S.A.
Vela Pharmaceuticals Inc.
ViaCell, Inc.
WHY: Pharmaceuticals continues to be one of the most rapidly
growing sectors in healthcare and 2005 will undoubtedly be
another promising year within this sector as new drug
approvals and launches spur growth and we see continued
differentiation within the sector.
WHEN: Monday, May 23 and Tuesday, May 24, 2005
WHERE: Grand Hyatt New York, Park Avenue at Grand Central, New York
City
WEBCAST: Live audio transmissions of company presentations will
be accessible via the UBS Investment Bank website at
www.ibb.ubs.com when the conference opens. Replays will be
available starting approximately three hours after the
initial presentation and will remain accessible for four
weeks.
REGISTER: Members of the media may register for the conference
by contacting Allison Chin-Leong at
allison.chin-leong@ubs.com or (212) 882-5693.
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion